Mutual of America Capital Management LLC reduced its position in CME Group Inc. (NASDAQ:CME – Free Report) by 3.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 45,407 shares of the financial services provider’s stock after selling 1,791 shares during the quarter. Mutual of America Capital Management LLC’s holdings in CME Group were worth $8,927,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also modified their holdings of the company. Aveo Capital Partners LLC purchased a new position in shares of CME Group in the fourth quarter worth $226,000. 9258 Wealth Management LLC lifted its holdings in shares of CME Group by 3.7% in the fourth quarter. 9258 Wealth Management LLC now owns 3,148 shares of the financial services provider’s stock worth $663,000 after buying an additional 113 shares in the last quarter. Gryphon Financial Partners LLC purchased a new position in shares of CME Group in the fourth quarter worth $547,000. Gladstone Institutional Advisory LLC purchased a new position in shares of CME Group in the fourth quarter worth $831,000. Finally, Coldstream Capital Management Inc. lifted its holdings in shares of CME Group by 6.5% in the fourth quarter. Coldstream Capital Management Inc. now owns 3,921 shares of the financial services provider’s stock worth $826,000 after buying an additional 238 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.
CME Group Price Performance
CME Group stock opened at $216.30 on Thursday. The firm has a 50-day moving average price of $207.08 and a 200-day moving average price of $207.54. The firm has a market capitalization of $77.88 billion, a PE ratio of 24.61, a price-to-earnings-growth ratio of 8.85 and a beta of 0.55. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $223.80.
CME Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be paid a $1.15 dividend. This represents a $4.60 annualized dividend and a yield of 2.13%. The ex-dividend date of this dividend is Monday, September 9th. CME Group’s dividend payout ratio is presently 52.33%.
Wall Street Analyst Weigh In
Several equities analysts have recently commented on the stock. Barclays boosted their target price on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a report on Thursday, July 25th. Keefe, Bruyette & Woods upped their price target on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research note on Thursday, July 25th. JPMorgan Chase & Co. upped their price target on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Piper Sandler reaffirmed an “overweight” rating and set a $225.00 price target on shares of CME Group in a research note on Tuesday, August 20th. Finally, Bank of America downgraded shares of CME Group from a “neutral” rating to an “underperform” rating and decreased their price target for the company from $212.00 to $177.00 in a research note on Tuesday, September 3rd. Four equities research analysts have rated the stock with a sell rating, five have issued a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $209.73.
View Our Latest Stock Report on CME
Insider Buying and Selling
In related news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by insiders.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
- Five stocks we like better than CME Group
- 5 Top Rated Dividend Stocks to Consider
- How Much Can You Make in Stocks in One Month?
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- This Is the Top Large-Cap Stock Insiders Are Buying
- What is a buyback in stocks? A comprehensive guide for investors
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.